Apolipoprotein E genotypes and cognitive functions in healthy elderly persons

Acta Neurologica Scandinavica

Volumn 100, Issue 1, 1999, Pages 53-60

  Staehelin, Hannes B ^a   Perrig Chiello, P ^b   Mitrache, C ^b   Miserez, A R ^b   Perrig, W J ^b  

^a Geriatrische Universitatsklinik   (Switzerland)

^b NONE

Author keywords

Aging; ApoE genotypes; Cognitive performance

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL;

AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; EDUCATION; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; LINGUISTICS; LONG TERM MEMORY; MALE; NORMAL HUMAN; RECALL; SEMANTICS;

EID: 0032970522     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1999.tb00723.x     Document Type: Article

References (40)

1. 1. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
2. 2. Mayeux R, Saunders AM, Shea S et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. N Engl J Med 1998;338:506-11.
3. 3. Levy-Lahad E, Lahad A, Wijsman EM, Bird TD, Schellenberg GD. Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Ann Neurol 1995;38:678-80.
4. 4. van Duijn CM, De Knijff P, Wehnert A et al. The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 1995;37:605-10.
5. 5. Blacker D, Haines JL, Rodes L et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 1997;48:139-47.
6. 6. Corder EH, Saunders AM, Risch NJ et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet 1994;7:180-4.
7. 7. Roses AD, Strittmatter WJ, Pericak VM, Corder EH, Saunders AM, Schmechel DE. Clinical application of apolipoprotein E genotyping to Alzheimer's disease. Lancet 1994;343(8912):1564-5.
8. 8. Farrer LA, Cupples LA, van Duijn CM et al. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives. Ann Neurol 1995;38:797-808.
9. 9. van Duijn CM, Havekes LM, Van Broeckhoven C et al. Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease. BMJ 1995;310:627-31.
10. 10. Slooter AJ, Tang MX, van Duijn CM et al. Apolipoprotein E epsilon 4 and the risk of dementia with stroke. A population-based investigation. Jama 1997;277(10):818-21.
11. 11. Kosunen O, Talasniemi S, Lehtovirta M et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 1995;26:743-8.
12. 12. Scheer WD, Boudreau DA, Malcom GT et al. Apolipoprotein E and atherosclerosis in Alaska natives. Atherosclerosis 1995;114:197-202.
13. 13. Wang XL, McCredie RM, Wilcken DE. Polymorphism of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol 1995;15:1030-4.
14. 14. Kuusisto J, Mykkänen L, Kervinen K et al. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995;15:1280-6.
15. 15. Lehtinen S, Lehtimäki T, Sisto T et al. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women. Atherosclerosis 1995;114:83-91.
16. 16. Polvikoski T, Sulkava R, Haltia M et al. Apolipoprotein E, dementia, and cortical deposition of -amyloid protein. N Engl J Med 1995;333:1242-7.
17. 17. Small GW, Mazziotta JC, Collins MT et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. Jama 1995;273(12):942-7.
18. 18. Reiman EM, Casflli RJ, Yun LS et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the 4 allele for apolipoprotein E. N Engl J Med 1996;334:752-8.
19. 19. Perrig-Chiello P, Perrig WJ, Staehelin HB et al. Autonomie, Wohlbefinden und Gesundheit im Alter. Das Basler IDA-Projekt. Zeitschrift fuer Gerontologie und Geriatrie 1996;29:95-109.
20. 20. Widmer LK, Staehelin HB, Nissen C, da Silva A. Venen-, Arterienkrankheiten, koronare Herzkrankheit bei Berufstaetigen. ("Basler Studie"). Bern: Hans Huber, 1981.
21. 21. Perrig WJ, Perrig P, Staehelin HR. The relation between antioxidants and memory performance in the old and very old. J Am Ger Soc 1997;45:718-24.
22. 22. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-8.
23. 23. Staehelin HB, Gey KF, Eichenholzer M et al. Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel Study. Am J Epidemiol 1991;133:766-75.
24. 24. Uetermann G, Hardewig A, Zimmer F. Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 1984;65(3):237-41.
25. 25. Feskens EJM, Havekes LM, Kalmijn S et al. Apolipoprotein ε4 allele and cognitive decline in elderly men. BMJ 1994;309:1202-5.
26. 26. Linn R, Wolf P, Bachman D et al. The "preclinical phase" of probable Alzheimer's disease. Arch Neurol 1995;52:485-490.
27. 27. Jacobs DM, Sano M, Dooneief G et al. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995;45:957-62.
28. 28. Salthouse TA. Theoretical perspectives on cognitive aging. Hillsdale, NJ: Erlbaum, 1995.
29. 29. Henderson AS, Easteal, S, Jorm AF et al. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-90.
30. 30. Hyman BT, Gomez-Isla T, Briggs M et al. Apolipoprotein E and cognitive change in an elderly population. Ann Neurol 1996;40:55-66.
31. 31. Reed T, Carmelli D, Swan G et al. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E4 allele. Arch Neurol 1994;51:1189-92.
32. 32. Bondi MW, Salmon DP, Monsch AU et al. Episodic memory changes are associated with the APOE-4 allele in nondemented older adults. Neurology 1995;45:2203-6.
33. 33. Helkala EL, Koivisto K, Hanninen T et al. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci Lett 1996;204(3):177-80.
34. 34. Schmidt H, Schmidt R, Fazekas F et al. Apolipoprotein E epsilon 4 allele in the normal elderly: neuropsychological and brain MRI correlates. Clin Genet 1996;50:293-9.
35. 35. Jarvik GP, Larson EB, Goddard K et al. Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. Am J Hum Genet 1996;58:191-200.
36. 36. Farrer LA, Cupples LA, Haines JL et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama 1997;278(16):1349-56.
37. 37. Petersen RC, Smith GE, Ivnik RJ et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals [published erratum appears in JAMA 1995 Aug 16; 274(7): 538]. Jama 1995;273(16):1274-8.
38. 37. Petersen RC, Smith GE, Ivnik RJ et al. ApolipoproteinE status as a predictor of the development of Alzheimer's disease in memory-impaired individuals[published erratum appears in JAMA 1995 Aug 16;274(7): 538]. Jama 1995;273(16):1274-8.
39. 38. Hofman A, Ott A, Breteler MM et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-4.
40. 39. Brenner DE, Kuhull WA, Van Belle G et al. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 1993;43:293-300.